What is the ticker symbol for Xenetic Biosciences?

Xenetic Biosciences trades under the ticker XBIO on NASDAQ.

What sector does Xenetic Biosciences operate in?

Xenetic Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze XBIO in a portfolio?

PortView shows XBIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Xenetic Biosciences (XBIO) Stock Analysis

NASDAQHealthcareBiotechnology

$4.18-1.25%

1-year price historyRange $2.02 – $10.36

52-week range$4.18

$1.90$13.93

What Xenetic Biosciences does

Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART. This cutting-edge personalized chimeric antigen receptor T cell (CAR T) platform is specifically engineered to identify and attack distinct tumor neoantigens found in individual patients. Beyond this specialized area, the company actively engages in the discovery, investigation, and creation of advanced biologic medicines and cancer treatments. A significant part of its cell-based therapeutic endeavors involves therapies designed to target the B-cell receptor on the exterior of malignant tumor cells in specific patients, with the aim of addressing B-cell lymphomas. Furthermore, Xenetic capitalizes on its proprietary drug delivery technology, PolyXen, through strategic alliances with various biotechnology and pharmaceutical enterprises. The company has established important collaborative agreements with partners including Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. has its headquarters located in Framingham, Massachusetts.

Key metrics

Market cap

$9.57M

P/E (TTM)

-3.48

EPS (TTM)

$-1.20

Beta

2.15

Dividend yield

0.00%

Revenue / share

$1.42

50-day avg

$3.05

200-day avg

$2.78

52-week high

$13.93

52-week low

$1.90

CEO

James F. Parslow

ETFs linked to XBIO

Broad-market and Healthcare sector ETFs an investor holding Xenetic Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how XBIO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze XBIO in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Xenetic Biosciences?: Xenetic Biosciences trades under the ticker XBIO on NASDAQ.
Which exchange is XBIO listed on?: XBIO is listed on NASDAQ.
What sector does Xenetic Biosciences operate in?: Xenetic Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze XBIO in a portfolio?: PortView shows XBIO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.